<p>挪威银行在第二季度购买了 Organon &amp; Co.（纽约证券交易所代码：OGN - 免费报告）的新股份，根据该公司最近向美国证券交易委员会（SEC）披露的信息。该基金购买了 2,043,153 股公司股票，价值约为 19,778,000 美元。截至最近的 SEC 备案，挪威银行持有 Organon &amp; Co.约 0.79% 的股份。</p>
<p>获取 <strong>Organon &amp; Co.</strong> 的提醒：</p>
<ul>
<li>道琼斯最热门的股票默克准备发布第四季度财报</li>
</ul>
<p>其他对冲基金和机构投资者也对该公司的持仓进行了调整。Ransom Advisory Ltd 在第一季度购买了价值约 32,000 美元的 Organon &amp; Co.新股份。Hanson &amp; Doremus Investment Management 在第二季度购买了价值约 26,000 美元的 Organon &amp; Co.新股份。Hantz Financial Services Inc.在第二季度将其在 Organon &amp; Co.的持仓提高了 293.8%。Hantz Financial Services Inc.现在拥有 2,674 股公司股票，价值 26,000 美元，此前在该期间内又购买了 1,995 股。Brooklyn Investment Group 在第一季度将其在 Organon &amp; Co.的股份增加了 1,012.3%。Brooklyn Investment Group 现在拥有 3,070 股公司股票，价值 46,000 美元，此前在上个季度又购买了 2,794 股。最后，BI Asset Management Fondsmaeglerselskab A S 在第一季度购买了价值约 51,000 美元的 Organon &amp; Co.新股份。77.43% 的股票由机构投资者持有。</p>
<h2>分析师评级变动</h2>
<p>一些股票分析师最近对该股票发布了报告。摩根士丹利将 Organon &amp; Co.的目标价格从 10.00 美元下调至 9.00 美元，并在 11 月 11 日的研究报告中对该公司给予了 “持平” 评级。摩根大通将 Organon &amp; Co.的目标价格从 14.00 美元下调至 12.00 美元，并在 11 月 11 日的研究报告中对该股票给予了 “减持” 评级。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Organon &amp; Co.的 “卖出（d+）” 评级。最后，Piper Sandler 将 Organon &amp; Co.的评级从 “增持” 下调至 “减持”，并设定了 5.00 美元的目标价格。在一位股票研究分析师的评级中，该股票获得了强烈买入评级，一位给予了买入评级，两位给予了持有评级，三位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “持有”，共识目标价格为 12.50 美元。</p>
<ul>
<li>Lululemon Athletica 因进入标准普尔 500 指数而创下新高</li>
</ul>
<p><strong>获取我们关于 OGN 的最新报告</strong></p>
<h2>Organon &amp; Co.股票上涨 2.3%</h2>
<p>Organon &amp; Co.的股票在周二以 7.30 美元开盘。该公司的 50 日移动平均价格为 8.22 美元，200 日移动平均价格为 9.21 美元。该公司的速动比率为 1.20，流动比率为 1.75，债务与股本比率为 9.69。Organon &amp; Co.的 12 个月低点为 6.18 美元，12 个月高点为 17.23 美元。该公司的市值为 19 亿美元，市盈率为 3.80，市盈率/增长比率为 1.53，贝塔系数为 0.57。</p>
<p>Organon &amp; Co.（纽约证券交易所代码：OGN - 获取免费报告）最近在 11 月 10 日发布了季度财报。该公司报告季度每股收益为 1.01 美元，超出市场共识预期的 0.93 美元，超出幅度为 0.08 美元。Organon &amp; Co.的股本回报率为 143.47%，净利润率为 7.95%。该公司在本季度的收入为 16 亿美元，而市场共识预期为 15.7 亿美元。在去年同期，该公司每股收益为 1.38 美元。整体来看，股票分析师预测 Organon &amp; Co.在当前年度的每股收益将达到 3.68 美元。</p>
<h2>Organon &amp; Co.股息公告</h2>
<p>该公司最近还宣布了一项季度股息，将于 12 月 11 日支付。11 月 20 日的股东将获得每股 0.02 美元的股息。这相当于年化股息 0.08 美元，股息收益率为 1.1%。该股息的除息日期为 11 月 20 日。Organon &amp; Co.目前的股息支付比率为 4.17%。</p>
<h2>关于 Organon &amp; Co.</h2>
<p>（免费报告）</p>
<p>Organon &amp; Co.是一家基于科学的全球制药公司，通过一系列处方疗法在女性健康、生物类似药和成熟品牌领域开发和提供创新健康解决方案。该公司成立于 2020 年 3 月 11 日，总部位于新泽西州泽西市。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Organon &amp; Co。</li>
<li>异常交易量的股票：如何实时找到异常交易量的股票</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑对消费者健康的影响</li>
<li>如何一步一步购买便宜股票</li>
<li>2026 年最有可能拆分的三只股票</li>
<li>动荡市场中的资产配置策略</li>
<li>ChargePoint 的复苏故事：为什么这只电动车股票再次上涨</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9HTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9HTg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Organon &amp; Co.吗？</h2>
<p>在考虑投资 Organon &amp; Co.之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Organon &amp; Co.并不在名单上。</p>
<p>虽然 Organon &amp; Co.目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

<p>挪威银行在第二季度收购了 2,043,153 股 Organon & Co.的股票，价值 1978 万美元。该股票的分析师评级不一，市场共识目标价为 12.50 美元。Organon & Co.报告第三季度每股收益为 1.01 美元，超出预期。公司宣布季度股息为每股 0.02 美元，将于 12 月 11 日支付</p>

<p>Norges Bank purchased a new position in shares of Organon &amp; Co. (NYSE:OGN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 2,043,153 shares of the company's stock, valued at approximately $19,778,000. Norges Bank owned about 0.79% of Organon &amp; Co. as of its most recent SEC filing.</p>
<div class="lb-trans"><p>挪威银行在第二季度购买了 Organon &amp; Co.（纽约证券交易所代码：OGN - 免费报告）的新股份，根据该公司最近向美国证券交易委员会（SEC）披露的信息。该基金购买了 2,043,153 股公司股票，价值约为 19,778,000 美元。截至最近的 SEC 备案，挪威银行持有 Organon &amp; Co.约 0.79% 的股份。</p>
</div><p>Get <strong>Organon &amp; Co.</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Organon &amp; Co.</strong> 的提醒：</p>
</div><ul>
<li>Merck, the Dow's hottest stock, gets set to report Q4 financials</li>
</ul>
<div class="lb-trans"><ul>
<li>道琼斯最热门的股票默克准备发布第四季度财报</li>
</ul>
</div><p>Other hedge funds and other institutional investors have also made changes to their positions in the company. Ransom Advisory Ltd bought a new position in shares of Organon &amp; Co. during the first quarter worth approximately $32,000. Hanson &amp; Doremus Investment Management bought a new stake in shares of Organon &amp; Co. in the second quarter valued at approximately $26,000. Hantz Financial Services Inc. lifted its position in Organon &amp; Co. by 293.8% during the second quarter. Hantz Financial Services Inc. now owns 2,674 shares of the company's stock worth $26,000 after purchasing an additional 1,995 shares during the period. Brooklyn Investment Group grew its stake in Organon &amp; Co. by 1,012.3% during the first quarter. Brooklyn Investment Group now owns 3,070 shares of the company's stock worth $46,000 after buying an additional 2,794 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new position in Organon &amp; Co. in the first quarter valued at approximately $51,000. 77.43% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他对冲基金和机构投资者也对该公司的持仓进行了调整。Ransom Advisory Ltd 在第一季度购买了价值约 32,000 美元的 Organon &amp; Co.新股份。Hanson &amp; Doremus Investment Management 在第二季度购买了价值约 26,000 美元的 Organon &amp; Co.新股份。Hantz Financial Services Inc.在第二季度将其在 Organon &amp; Co.的持仓提高了 293.8%。Hantz Financial Services Inc.现在拥有 2,674 股公司股票，价值 26,000 美元，此前在该期间内又购买了 1,995 股。Brooklyn Investment Group 在第一季度将其在 Organon &amp; Co.的股份增加了 1,012.3%。Brooklyn Investment Group 现在拥有 3,070 股公司股票，价值 46,000 美元，此前在上个季度又购买了 2,794 股。最后，BI Asset Management Fondsmaeglerselskab A S 在第一季度购买了价值约 51,000 美元的 Organon &amp; Co.新股份。77.43% 的股票由机构投资者持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>A number of equities analysts recently issued reports on the stock. Morgan Stanley lowered their price objective on shares of Organon &amp; Co. from $10.00 to $9.00 and set an &#34;equal weight&#34; rating for the company in a research report on Tuesday, November 11th. JPMorgan Chase &amp; Co. reduced their price objective on shares of Organon &amp; Co. from $14.00 to $12.00 and set an &#34;underweight&#34; rating on the stock in a research note on Tuesday, November 11th. Weiss Ratings reiterated a &#34;sell (d+)&#34; rating on shares of Organon &amp; Co. in a research note on Wednesday, October 8th. Finally, Piper Sandler cut Organon &amp; Co. from an &#34;overweight&#34; rating to an &#34;underweight&#34; rating and set a $5.00 target price on the stock. in a report on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of &#34;Hold&#34; and a consensus target price of $12.50.</p>
<div class="lb-trans"><p>一些股票分析师最近对该股票发布了报告。摩根士丹利将 Organon &amp; Co.的目标价格从 10.00 美元下调至 9.00 美元，并在 11 月 11 日的研究报告中对该公司给予了 “持平” 评级。摩根大通将 Organon &amp; Co.的目标价格从 14.00 美元下调至 12.00 美元，并在 11 月 11 日的研究报告中对该股票给予了 “减持” 评级。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Organon &amp; Co.的 “卖出（d+）” 评级。最后，Piper Sandler 将 Organon &amp; Co.的评级从 “增持” 下调至 “减持”，并设定了 5.00 美元的目标价格。在一位股票研究分析师的评级中，该股票获得了强烈买入评级，一位给予了买入评级，两位给予了持有评级，三位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “持有”，共识目标价格为 12.50 美元。</p>
</div><ul>
<li>Lululemon Athletica Races to New High with S&amp;P 500 Entry</li>
</ul>
<div class="lb-trans"><ul>
<li>Lululemon Athletica 因进入标准普尔 500 指数而创下新高</li>
</ul>
</div><p><strong>Get Our Latest Report on OGN</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 OGN 的最新报告</strong></p>
</div><h2>Organon &amp; Co. Stock Up 2.3%</h2>
<div class="lb-trans"><h2>Organon &amp; Co.股票上涨 2.3%</h2>
</div><p>Organon &amp; Co. stock opened at $7.30 on Tuesday. The firm has a 50 day moving average price of $8.22 and a 200-day moving average price of $9.21. The company has a quick ratio of 1.20, a current ratio of 1.75 and a debt-to-equity ratio of 9.69. Organon &amp; Co. has a twelve month low of $6.18 and a twelve month high of $17.23. The company has a market capitalization of $1.90 billion, a P/E ratio of 3.80, a P/E/G ratio of 1.53 and a beta of 0.57.</p>
<div class="lb-trans"><p>Organon &amp; Co.的股票在周二以 7.30 美元开盘。该公司的 50 日移动平均价格为 8.22 美元，200 日移动平均价格为 9.21 美元。该公司的速动比率为 1.20，流动比率为 1.75，债务与股本比率为 9.69。Organon &amp; Co.的 12 个月低点为 6.18 美元，12 个月高点为 17.23 美元。该公司的市值为 19 亿美元，市盈率为 3.80，市盈率/增长比率为 1.53，贝塔系数为 0.57。</p>
</div><p>Organon &amp; Co. (NYSE:OGN - Get Free Report) last posted its quarterly earnings data on Monday, November 10th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.93 by $0.08. Organon &amp; Co. had a return on equity of 143.47% and a net margin of 7.95%.The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter in the prior year, the business earned $1.38 earnings per share. As a group, equities analysts predict that Organon &amp; Co. will post 3.68 EPS for the current year.</p>
<div class="lb-trans"><p>Organon &amp; Co.（纽约证券交易所代码：OGN - 获取免费报告）最近在 11 月 10 日发布了季度财报。该公司报告季度每股收益为 1.01 美元，超出市场共识预期的 0.93 美元，超出幅度为 0.08 美元。Organon &amp; Co.的股本回报率为 143.47%，净利润率为 7.95%。该公司在本季度的收入为 16 亿美元，而市场共识预期为 15.7 亿美元。在去年同期，该公司每股收益为 1.38 美元。整体来看，股票分析师预测 Organon &amp; Co.在当前年度的每股收益将达到 3.68 美元。</p>
</div><h2>Organon &amp; Co. Dividend Announcement</h2>
<div class="lb-trans"><h2>Organon &amp; Co.股息公告</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Thursday, December 11th. Stockholders of record on Thursday, November 20th will be given a dividend of $0.02 per share. This represents a $0.08 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend is Thursday, November 20th. Organon &amp; Co.'s dividend payout ratio is currently 4.17%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度股息，将于 12 月 11 日支付。11 月 20 日的股东将获得每股 0.02 美元的股息。这相当于年化股息 0.08 美元，股息收益率为 1.1%。该股息的除息日期为 11 月 20 日。Organon &amp; Co.目前的股息支付比率为 4.17%。</p>
</div><h2>About Organon &amp; Co.</h2>
<div class="lb-trans"><h2>关于 Organon &amp; Co.</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Organon &amp; Co is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.</p>
<div class="lb-trans"><p>Organon &amp; Co.是一家基于科学的全球制药公司，通过一系列处方疗法在女性健康、生物类似药和成熟品牌领域开发和提供创新健康解决方案。该公司成立于 2020 年 3 月 11 日，总部位于新泽西州泽西市。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Organon &amp; Co.</li>
<li>Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time</li>
<li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li>
<li>How to Buy Cheap Stocks Step by Step</li>
<li>3 Stocks Most Likely to Split in 2026</li>
<li>Asset Allocation Strategies in Volatile Markets</li>
<li>ChargePoint's Comeback Story: Why This EV Stock Is Charging Up Again</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Organon &amp; Co。</li>
<li>异常交易量的股票：如何实时找到异常交易量的股票</li>
<li>Dollar Tree 的激增和 Home Depot 的下滑对消费者健康的影响</li>
<li>如何一步一步购买便宜股票</li>
<li>2026 年最有可能拆分的三只股票</li>
<li>动荡市场中的资产配置策略</li>
<li>ChargePoint 的复苏故事：为什么这只电动车股票再次上涨</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9HTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OGN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Organon &amp; Co. Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Organon &amp; Co.吗？</h2>
</div><p>Before you consider Organon &amp; Co., you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 Organon &amp; Co.之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organon &amp; Co. wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Organon &amp; Co.并不在名单上。</p>
</div><p>While Organon &amp; Co. currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Organon &amp; Co.目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

挪威银行在 Organon & Co. $OGN 中建立了 1978 万美元的头寸